Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunshan Double Crane Pharmaceutical is a Chinese pharmaceutical manufacturer based in Kunshan, Jiangsu, and operates as a subsidiary of China Resources Double Crane Pharmaceutical. The company specializes in the production of chemical drug preparations, with a significant focus on chronic disease management, particularly in the fields of endocrinology and cardiovascular health. Its core product portfolio includes essential generic medications such as metformin hydrochloride and gliclazide for diabetes, as well as various anti-infective and antihypertensive agents. Kunshan Double Crane operates modern manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards, serving as a key production hub for its parent group's domestic market strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunshan Double Crane Pharmaceutical.